Evaluation of the usefulness of red blood cell distribution width in critically ill pediatric patients

Da Hyun Kim1, Eun Ju Ha, Seong Jong Park

  • 1Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Medicine
|September 9, 2020
PubMed

Insights

Higher red blood cell distribution width (RDW) in children admitted to the pediatric intensive care unit (PICU) is linked to increased mortality. RDW is an independent risk factor for PICU death and improves existing predictive scores.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Prognostic biomarkers

Background:

  • Red blood cell distribution width (RDW) measures erythrocyte size variability and is a known prognostic marker in adults.
  • Limited research exists on RDW's prognostic value in critically ill children.
  • Understanding prognostic markers in pediatric intensive care units (PICUs) is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the association between RDW and mortality in critically ill children admitted to the PICU.
  • To determine if RDW is an independent risk factor for PICU mortality.
  • To assess the impact of incorporating RDW into existing pediatric mortality prediction scores.

Main Methods:

  • Retrospective analysis of 960 children admitted to the PICU between November 2012 and May 2018.
  • Evaluation of RDW levels and correlation with clinical parameters, severity scores (e.g., PELOD-2), and PICU mortality.
  • Multivariate logistic regression analysis to identify independent risk factors for mortality.

Main Results:

  • Higher RDW values (≥14.5%) were associated with increased use of vasoactive drugs, mechanical ventilation, and higher severity scores.
  • Patients with higher RDW groups exhibited significantly higher PICU mortality rates compared to the lowest RDW group.
  • Elevated RDW (≥14.5%) was identified as an independent risk factor for PICU mortality, even after adjusting for age and sex.

Conclusions:

  • Increased RDW is significantly associated with adverse clinical parameters and higher mortality in critically ill children.
  • RDW serves as an independent predictor of PICU mortality in the pediatric population.
  • Adding RDW to the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) score significantly improved its predictive performance for PICU mortality.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
168
Volume of Distribution01:20

Volume of Distribution

The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
905
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
139
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131